CELIXIR
Cell Therapy Limited
Application Filed: 2017-01-12
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79205912 |
| Registration Number | 5420465 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Bess Morgan |
| Attorney Docket Number | 221834-00012 |
| Law Office Assigned | N20 |
| Employee Name | O'BRIEN, JENNIFER LYNN |
Timeline
| 2017-01-12 | Application Filed |
| 2017-12-26 | Published for Opposition |
| 2018-03-13 | Location: PUBLICATION AND ISSUE SECTION |
| 2018-03-13 | Status: Live/Registered |
| 2018-03-13 | Trademark Registered |
| 2019-10-25 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Cell Therapy Limited |
| Entity Statement | limited company (ltd.) |
| Address | The Maynard Centre, Block CD1, Room 1:62 Forest Farm Industrial Estate Longwood Drive Cardiff CF14 7YT GB |
| Legal Entity Type | |
| Legal Entity State | GB |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the treatment of damaged skin, tissue, organs and body parts; pharmaceutical preparations for the treatment of diseased skin, tissue, organs and body parts in the nature of treatment for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; veterinary pharmaceutical preparations for the treatment of damaged or diseased skin, tissue, organs and body parts; pharmaceutical and veterinary pharmaceutical preparations for use in promoting cellular, tissue, and organ regeneration; pharmaceutical and veterinary pharmaceutical preparations for use in regenerative medicine; pharmaceutical preparations and substances for the treatment of damaged skin and tissue, namely, tissue regenerative pharmaceutical preparations; cellular medicines, namely, stem cells for medical or veterinary use |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2017-04-27 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-05-01 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2017-05-01 | 3 DOCK D:Assigned to Examiner |
| APPLICATION FILING RECEIPT MAILED | 2017-05-05 | 4 MAFR O:Outgoing Correspondence |
| NON-FINAL ACTION WRITTEN | 2017-05-08 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2017-05-09 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2017-05-16 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2017-05-16 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2017-06-03 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-07-25 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-07-25 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-07-26 | 12 TEME I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2017-08-04 | 13 TCCA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2017-08-04 | 14 TCCA I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2017-08-17 | 15 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2017-08-17 | 16 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2017-08-17 | 17 GNFN O:Outgoing Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2017-11-14 | 18 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2017-11-14 | 19 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2017-11-14 | 20 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2017-11-14 | 21 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-11-16 | 22 CNSA O:Outgoing Correspondence |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2017-12-06 | 23 OP2R P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-12-06 | 24 NONP E:E-Mail |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2017-12-06 | 25 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2017-12-22 | 26 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2017-12-26 | 27 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-12-26 | 28 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2018-03-13 | 29 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2018-06-13 | 30 FICR P: |
| FINAL DISPOSITION PROCESSED | 2018-06-21 | 31 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2018-06-21 | 32 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2018-07-20 | 33 FINO P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2019-10-25 | 34 NREP P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2021-12-04 | 35 NREP P: |
| COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | 2023-03-13 | 36 REM3 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 CELIXIR 88661598 not registered Live/Pending |
CELIXIR PHARMACY LIMITED 2019-10-21 |
 CELIXIR 79205912 5420465 Live/Registered |
Cell Therapy Limited 2017-01-12 |
 CELIXIR 75494710 not registered Dead/Abandoned |
Scientific Resources Inc. 1998-05-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 